70 related articles for article (PubMed ID: 7872689)
1. In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenografts.
Jamshidipour R; Pinho EB; Howell SB
Anticancer Res; 1994; 14(6B):2611-6. PubMed ID: 7872689
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line.
Jamshidipour R; Pinho EB; Hom DK; Howell SB
Cancer Chemother Pharmacol; 1994; 34(6):484-90. PubMed ID: 7923559
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
Fan Z; Baselga J; Masui H; Mendelsohn J
Cancer Res; 1993 Oct; 53(19):4637-42. PubMed ID: 8402640
[TBL] [Abstract][Full Text] [Related]
4. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitivity of human pancreatic cancer cell lines serially transplanted in nude mouse.
Tomikawa M; Kubota T; Takahashi S; Matsuzaki SW; Kitajima M
Anticancer Res; 1998; 18(2A):1059-62. PubMed ID: 9615765
[TBL] [Abstract][Full Text] [Related]
6. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
8. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
9. Mitomycin C and cisplatin increase survival in a human pancreatic cancer metastatic model.
Tomikawa M; Kubota T; Matsuzaki SW; Takahasi S; Kitajima M; Moosa AR; Hoffman RM
Anticancer Res; 1997; 17(5A):3623-5. PubMed ID: 9413214
[TBL] [Abstract][Full Text] [Related]
10. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
[TBL] [Abstract][Full Text] [Related]
11. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
[TBL] [Abstract][Full Text] [Related]
13. A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer.
Abbruzzese JL; Gholson CF; Daugherty K; Larson E; DuBrow R; Berlin R; Levin B
Pancreas; 1992; 7(2):165-71. PubMed ID: 1553366
[TBL] [Abstract][Full Text] [Related]
14. [Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].
Shimazoe T; Funakoshi A; Kono A
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1321-5. PubMed ID: 1503487
[TBL] [Abstract][Full Text] [Related]
15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice.
Avila GE; Zheng X; Cui XX; Ryan AD; Hansson A; Suh J; Rabson AB; Chang RL; Shih WJ; Lin Y; Crowell P; Lu YP; Lou YR; Conney AH
J Pharmacol Exp Ther; 2005 Oct; 315(1):170-87. PubMed ID: 15976015
[TBL] [Abstract][Full Text] [Related]
17. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice].
Zhang P; He JB; Ou LW; Wang XH
Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671
[TBL] [Abstract][Full Text] [Related]
18. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
Li D; Williams JI; Pietras RJ
Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
[TBL] [Abstract][Full Text] [Related]
19. Identification of gastrin as a growth peptide in human pancreatic cancer.
Smith JP; Fantaskey AP; Liu G; Zagon IS
Am J Physiol; 1995 Jan; 268(1 Pt 2):R135-41. PubMed ID: 7840313
[TBL] [Abstract][Full Text] [Related]
20. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]